cytokines

Daniella Schwartz (left) and daughters
Member Highlights

Member Highlights Interview with Signals+ Co-Editor-in-Chief Daniella Schwartz

January 24, 2024

I like to think of myself as bivalent – kind of like the COVID vaccine. A big chunk of my lab’s work focuses on the regulation of IL-9 and the functions of IL-9 in the context of autoimmune and autoinflammatory (rheumatic) diseases. But I also have a growing program studying the genetic architecture of autoimmune and autoinflammatory conditions, based on rare/monogenic variants. This includes managing one of the only coordinated adult-pediatric autoinflammatory diagnosis/treatment programs in the US.  [READ MORE]

img-2
Member Highlights

Member Highlights Interview with Shruti Naik, PhD, an Active Member of the ICIS-ECR Committee

January 15, 2024

ICIS is a truly inclusive and global community of scientists. ICIS is exceptional at promoting trainees and faulty at all career stages and has promoted me and also trainees in my lab through awards and travel fellowships. The Cytokines meeting have been an unparalleled platform for networking with colleagues and identifying new collaborators… [READ MORE]

img-3
Member Highlights

Member Highlights Interview with ECR Committee Co-Chair Juan Mendoza

January 15, 2024

Favorite Cytokines Meeting: While I have loved each of the meetings, the most memorable was in Kanazawa, Japan 2017 because that is when I met several of my IFN idols: Ludmila Prokunina-Olsson (NIH), Sergei Kotenko (Rutgers), and Rune Hartmann (Aarhus University). [READ MORE]

img-4
Members in the News

Forever Young!

December 12, 2023

Howard A. Young PhD has announced he is entering emeritus status after four decades at the National Cancer Institute, National Institutes of Health. The ICIS owes much to Howard and this article seeks to acknowledge his many contributions to us, to other scientific organizations, to scientists and to science. [READ MORE]